文献速递急性肾损伤

克服急性肾损伤临床试验设计与实施中的障碍:2020年肾脏病临床试验学者会议报告

Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

急性肾损伤(AKI)与死亡、慢性肾脏病(CKD)和心血管事件风险增加独立相关,但随机对照试验(RCT)挑战大且常得出不确定结论,根源在于AKI病因、表现和病程的异质性。本文基于2020年肾脏病临床试验学者(KDCT)会议,叙述性综述了改善AKI临床试验设计与实施的障碍和策略,包括预测性和预后性富集技术、实用性试验和适应性试验。

要点

  • AKI是一种综合征,需识别亚表型以阐明病因并制定有效防治策略。
  • 传统RCT物流繁琐且患者高度选择,限制外部推广性,应考虑替代试验设计。
  • 预测性和预后性富集、实用性试验和适应性试验是改善AKI试验设计的策略。

核心结论

  • AKI临床试验面临障碍,需采用富集技术、实用性试验和适应性试验等策略改进设计与实施。

研究设计与样本

  • 基于2020年肾脏病临床试验学者(KDCT)会议的叙述性综述。

主要发现

  • AKI与死亡、CKD和心血管事件风险增加独立相关。
  • AKI的病因、表现和病程异质性导致传统RCT常得出不确定结论。
  • 传统RCT物流繁琐且患者高度选择,限制外部推广性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute kidney injury (AKI) is a growing epidemic and is independently associated with increased risk of death, chronic kidney disease (CKD) and cardiovascular events. Randomized-controlled trials (RCTs) in this domain are notoriously challenging and many clinical studies in AKI have yielded inconclusive findings. Underlying this conundrum is the inherent heterogeneity of AKI in its etiology, presentation and course. AKI is best understood as a syndrome and identification of AKI subphenotypes is needed to elucidate the disease's myriad etiologies and to tailor effective prevention and treatment strategies. Conventional RCTs are logistically cumbersome and often feature highly selected patient populations that limit external generalizability and thus alternative trial designs should be considered when appropriate. In this narrative review of recent developments in AKI trials based on the Kidney Disease Clinical Trialists (KDCT) 2020 meeting, we discuss barriers to and strategies for improved design and implementation of clinical trials for AKI patients, including predictive and prognostic enrichment techniques, the use of pragmatic trials and adaptive trials.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lazzareschi D, Mehta RL, Dember LM, et al. Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting. Nephrol Dial Transplant. 2023. PMID: 35022767. doi:10.1093/ndt/gfac003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。